Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2004; 43:25-32
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pietra, G. G.
Right arrow Articles by Tuder, R. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Pietra, G. G.
Right arrow Articles by Tuder, R. M.

Pathologic assessment of vasculopathies in pulmonary hypertension

Giuseppe G. Pietra, MD*,*, Frederique Capron, MD{dagger}, Susan Stewart, MD{ddagger}, Ornella Leone, MD§, Marc Humbert, MD, Ivan M. Robbins, MD, Lynne M. Reid, MD|| and R. M. Tuder, MD**

* Department of Pathology, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania, USA
{dagger} Service d'Anatomie Pathologique 1, Hôpital de la Pitié, 83, bd de l'Hôpital 75651 Paris Cedex, 13, France
{ddagger} Papworth Hospital, Papworth Everard, Cambridge, United Kingdom
§ Department of Pathology, Azienda Ospedaliera S. Orsola-Malpighi of Bologna, Bologna, Italy
Service de Pneumologie et Réanimation Respiratoire, Hôpital Antoine Béclère, Assistance Publique, Hôpitaux de Paris, Université Paris-Sud, Clamart, France
Vanderbilt University Medical Center, Adult Pulmonary Hypertension Center, Vanderbilt University, Nashville, Tennessee, USA
|| Department of Pathology, Harvard Medical School, Boston, MassachusettsBaltimore, Maryland, USA
** Division of Cardiopulmonary Pathology, The Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA

Manuscript received November 26, 2003; accepted February 3, 2004.

* Reprint requests and correspondence: Dr. Giuseppe G. Pietra, Via San Giorgio 23, CH 6976 Castagnola, Switzerland.
gkpietra{at}freesurf.ch

Pulmonary arterial hypertension (PAH) includes various forms of pulmonary hypertension of different etiology but similar clinical presentation and functional derangement. Histopathological vascular changes in all forms of PAH are qualitatively similar but with quantitative differences in the distribution and prevalence of pathological changes in various portions of the pulmonary vascular bed. The documentation of these topographic variations in the response of the pulmonary vasculature to injury may be important to understand the pathogenesis of the various subsets of PAH. To standardize the precise histopathological documentation of the pulmonary vasculopathy in PAH we propose a histopathological classification that includes both the predominant segment of the pulmonary vasculature affected and the possible coexistence of pathological changes in other vascular segments.

Abbreviations and Acronyms
  BMPR2 = Bone morphometric protein receptor-2
  HIV = human immunodeficiency virus
  PAH = pulmonary arterial hypertension
  PCH = pulmonary capillary hemangiomatosis
  PM = pulmonary microvasculopathy
  POV = pulmonary occlusive venopathy
  PPH = primary pulmonary hypertension
  PVOD = pulmonary veno-occlusive disease




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. Zhang, L. Zhou, Q. Li, J. Liu, W. Yao, and H. Wan
Up-Regulation of Two Actin-Associated Proteins Prompts Pulmonary Artery Smooth Muscle Cell Migration under Hypoxia
Am. J. Respir. Cell Mol. Biol., October 1, 2009; 41(4): 467 - 475.
[Abstract] [Full Text] [PDF]


Home page
The Journal of RheumatologyHome page
D. B. BADESCH, M. D. McGOON, R. J. BARST, V. F. TAPSON, L. J. RUBIN, F. M. WIGLEY, K. M. KRAL, I. H. RAPHIOU, and G. D. CRATER
Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol
J Rheumatol, October 1, 2009; 36(10): 2244 - 2249.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. J. Overbeek, M. C. Vonk, A. Boonstra, A. E. Voskuyl, A. Vonk-Noordegraaf, E. F. Smit, B. A. C. Dijkmans, P. E. Postmus, W. J. Mooi, Y. Heijdra, et al.
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
Eur. Respir. J., August 1, 2009; 34(2): 371 - 379.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. L. Burke, M. G. Frid, C. L. Kunrath, V. Karoor, A. Anwar, B. D. Wagner, D. Strassheim, and K. R. Stenmark
Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment
Am J Physiol Lung Cell Mol Physiol, August 1, 2009; 297(2): L238 - L250.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. M. Tuder, S. H. Abman, T. Braun, F. Capron, T. Stevens, P. A. Thistlethwaite, and S. G. Haworth
Development and pathology of pulmonary hypertension.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S3 - S9.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Harch, H. Whitford, and C. McLean
Failure of Medical Therapy in Pulmonary Arterial Hypertension: Is There an Alternative Diagnosis?
Chest, June 1, 2009; 135(6): 1462 - 1469.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. V. McLaughlin, S. L. Archer, D. B. Badesch, R. J. Barst, H. W. Farber, J. R. Lindner, M. A. Mathier, M. D. McGoon, M. H. Park, R. S. Rosenson, et al.
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association Developed in Collaboration With the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association
J. Am. Coll. Cardiol., April 28, 2009; 53(17): 1573 - 1619.
[Full Text] [PDF]


Home page
CirculationHome page
Writing Committee Members, V. V. McLaughlin, S. L. Archer, D. B. Badesch, R. J. Barst, H. W. Farber, J. R. Lindner, M. A. Mathier, M. D. McGoon, M. H. Park, et al.
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association
Circulation, April 28, 2009; 119(16): 2250 - 2294.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Beghetti and N. Galie
Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension.
J. Am. Coll. Cardiol., March 3, 2009; 53(9): 733 - 740.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. K. Steiner, O. L. Syrkina, N. Kolliputi, E. J. Mark, C. A. Hales, and A. B. Waxman
Interleukin-6 Overexpression Induces Pulmonary Hypertension
Circ. Res., January 30, 2009; 104(2): 236 - 244.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. Montani, L. C. Price, P. Dorfmuller, L. Achouh, X. Jais, A. Yaici, O. Sitbon, D. Musset, G. Simonneau, and M. Humbert
Pulmonary veno-occlusive disease
Eur. Respir. J., January 1, 2009; 33(1): 189 - 200.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
C. S. Elangbam
REVIEW PAPER: Current Strategies in the Development of Anti-obesity Drugs and Their Safety Concerns
Vet. Pathol., January 1, 2009; 46(1): 10 - 24.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Rich and M. Rabinovitch
Diagnosis and Treatment of Secondary (Non-Category 1) Pulmonary Hypertension
Circulation, November 18, 2008; 118(21): 2190 - 2199.
[Full Text] [PDF]


Home page
Eur Respir JHome page
A. Chaouat, R. Naeije, and E. Weitzenblum
Pulmonary hypertension in COPD
Eur. Respir. J., November 1, 2008; 32(5): 1371 - 1385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. Perros, D. Montani, P. Dorfmuller, I. Durand-Gasselin, C. Tcherakian, J. Le Pavec, M. Mazmanian, E. Fadel, S. Mussot, O. Mercier, et al.
Platelet-derived Growth Factor Expression and Function in Idiopathic Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., July 1, 2008; 178(1): 81 - 88.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Homma, T. Nagaoka, V. Karoor, M. Imamura, L. Taraseviciene-Stewart, L. A. Walker, K. A. Fagan, I. F. McMurtry, and M. Oka
Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone
Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L71 - L78.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. Behr and J. H. Ryu
Pulmonary hypertension in interstitial lung disease
Eur. Respir. J., June 1, 2008; 31(6): 1357 - 1367.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. R. Stewart, J. D. Cogan, M. R. Kramer, W. T. Miller Jr, L. E. Christiansen, M. W. Pauciulo, L. M. Messiaen, G. S. Tu, W. H. Thompson, R. E. Pyeritz, et al.
Is Pulmonary Arterial Hypertension in Neurofibromatosis Type 1 Secondary to a Plexogenic Arteriopathy?
Chest, September 1, 2007; 132(3): 798 - 808.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. R. Bauer, T. M. Moore, and I. F. McMurtry
Rodent models of PAH: are we there yet?
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L580 - L582.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Arciniegas, M. G. Frid, I. S. Douglas, and K. R. Stenmark
Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L1 - L8.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Zakrzewicz, M. Hecker, L. M. Marsh, G. Kwapiszewska, B. Nejman, L. Long, W. Seeger, R. T. Schermuly, N. W. Morrell, R. E. Morty, et al.
Receptor for Activated C-Kinase 1, a Novel Interaction Partner of Type II Bone Morphogenetic Protein Receptor, Regulates Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension
Circulation, June 12, 2007; 115(23): 2957 - 2968.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
F. Perros, P. Dorfmuller, R. Souza, I. Durand-Gasselin, V. Godot, F. Capel, S. Adnot, S. Eddahibi, M. Mazmanian, E. Fadel, et al.
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension
Eur. Respir. J., May 1, 2007; 29(5): 937 - 943.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
A. A. Frazier, T. J. Franks, T.-L. H. Mohammed, I. H. Ozbudak, and J. R. Galvin
From the Archives of the AFIP: Pulmonary Veno-occlusive Disease and Pulmonary Capillary Hemangiomatosis
RadioGraphics, May 1, 2007; 27(3): 867 - 882.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. S. McMurtry, R. Moudgil, K. Hashimoto, S. Bonnet, E. D. Michelakis, and S. L. Archer
Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension
Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L872 - L878.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. T. Crossno Jr., C. V. Garat, J. E. B. Reusch, K. G. Morris, E. C. Dempsey, I. F. McMurtry, K. R. Stenmark, and D. J. Klemm
Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling
Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L885 - L897.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. M. Assaad, S. M. Kawut, S. M. Arcasoy, E. B. Rosenzweig, J. S. Wilt, J. R. Sonett, and A. C. Borczuk
Platelet-Derived Growth Factor Is Increased in Pulmonary Capillary Hemangiomatosis
Chest, March 1, 2007; 131(3): 850 - 855.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
J. H. Ryu, M. J. Krowka, K. L. Swanson, P. A. Pellikka, and M. D. McGoon
Pulmonary Hypertension in Patients With Interstitial Lung Diseases
Mayo Clin. Proc., March 1, 2007; 82(3): 342 - 350.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
G. P. McCann, C. T. Gan, A. M. Beek, H. W. M. Niessen, A. V. Noordegraaf, and A. C. van Rossum
Extent of MRI Delayed Enhancement of Myocardial Mass Is Related to Right Ventricular Dysfunction in Pulmonary Artery Hypertension
Am. J. Roentgenol., February 1, 2007; 188(2): 349 - 355.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. V. McLaughlin and M. D. McGoon
Pulmonary Arterial Hypertension
Circulation, September 26, 2006; 114(13): 1417 - 1431.
[Full Text] [PDF]


Home page
JEMHome page
B. S. Zuckerbraun, B. Y. Chin, B. Wegiel, T. R. Billiar, E. Czsimadia, J. Rao, L. Shimoda, E. Ifedigbo, S. Kanno, and L. E. Otterbein
Carbon monoxide reverses established pulmonary hypertension
J. Exp. Med., September 4, 2006; 203(9): 2109 - 2119.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Ulrich, M. Fischler, R. Speich, V. Popov, and M. Maggiorini
Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties.
Chest, September 1, 2006; 130(3): 841 - 846.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. D. Cogan, M. W. Pauciulo, A. P. Batchman, M. A. Prince, I. M. Robbins, L. K. Hedges, K. C. Stanton, L. A. Wheeler, J. A. Phillips III, J. E. Loyd, et al.
High Frequency of BMPR2 Exonic Deletions/Duplications in Familial Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., September 1, 2006; 174(5): 590 - 598.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. C. Marecki, C. D. Cool, J. E. Parr, V. E. Beckey, P. A. Luciw, A. F. Tarantal, A. Carville, R. P. Shannon, A. Cota-Gomez, R. M. Tuder, et al.
HIV-1 Nef Is Associated with Complex Pulmonary Vascular Lesions in SHIV-nef-infected Macaques
Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 437 - 445.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
O. Sanchez, O. Sitbon, X. Jais, G. Simonneau, and M. Humbert
Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension.
Chest, July 1, 2006; 130(1): 182 - 189.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
T. S. Zabka, F. E. Campbell, and D. W. Wilson
Pulmonary arteriopathy and idiopathic pulmonary arterial hypertension in six dogs.
Vet. Pathol., July 1, 2006; 43(4): 510 - 522.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M H Williams, C Das, C E Handler, M R Akram, J Davar, C P Denton, C J Smith, C M Black, and J G Coghlan
Systemic sclerosis associated pulmonary hypertension: improved survival in the current era
Heart, July 1, 2006; 92(7): 926 - 932.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Rabiller, X. Jais, A. Hamid, A. Resten, F. Parent, R. Haque, F. Capron, O. Sitbon, G. Simonneau, and M. Humbert
Occult alveolar haemorrhage in pulmonary veno-occlusive disease
Eur. Respir. J., January 1, 2006; 27(1): 108 - 113.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
L. Mouthon, L. Guillevin, and M. Humbert
Pulmonary arterial hypertension: an autoimmune disease?
Eur. Respir. J., December 1, 2005; 26(6): 986 - 988.
[Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. Zaiman, I. Fijalkowska, P. M. Hassoun, and R. M. Tuder
One Hundred Years of Research in the Pathogenesis of Pulmonary Hypertension
Am. J. Respir. Cell Mol. Biol., November 1, 2005; 33(5): 425 - 431.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. J. Rubin and D. B. Badesch
Evaluation and Management of the Patient with Pulmonary Arterial Hypertension
Ann Intern Med, August 16, 2005; 143(4): 282 - 292.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Richter, M. E. Yeager, A. Zaiman, C. D. Cool, N. F. Voelkel, and R. M. Tuder
Impaired Transforming Growth Factor-{beta} Signaling in Idiopathic Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1340 - 1348.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement